Fulgent Genetics (FLGT) Asset Utilization Ratio (2016 - 2026)
Fulgent Genetics (FLGT) posted Asset Utilization Ratio of 0.21 for Q2 2026, up 7.13% sequentially from 0.2 in Q1 2026, and down 14.86% YoY from 0.25 in Q2 2025.
Fulgent Genetics (FLGT) Asset Utilization Ratio (2016 - 2026) Analysis & Trends
Fulgent Genetics has reported Asset Utilization Ratio for 11 years, with the latest figure at 0.21 in Q2 2026.
- Quarterly Asset Utilization Ratio fell 14.86% year-over-year to 0.21 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.21 (down 14.86% YoY) and the FY2025 annual result came in at 0.27, up 14.85% from the prior year.
- Asset Utilization Ratio rose to 0.21 in Q2 2026 per FLGT's latest filing, from 0.2 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.69 in Q1 2022 and troughed at 0.2 in Q4 2025.
- A 5-year average of 0.31 and a median of 0.24 in 2023 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio sank 62.55% in 2023, then rose 16.03% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.45 in 2022, then slumped by 50.97% to 0.22 in 2023, then gained by 3.61% to 0.23 in 2024, then dropped by 14.54% to 0.2 in 2025, then grew by 8.7% to 0.21 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.21, 0.2, and 0.2 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 0.41 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 0.29 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 1.03 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 0.56 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 0.57 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 1.33 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 0.68 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 1.13 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 0.76 |
| 10 | Fulgent Genetics | 557.44 Mn | 300.41 Mn | 25.68 Mn | 0.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.21 |
| Mar 31, 2026 | 0.20 |
| Dec 31, 2025 | 0.20 |
| Sep 30, 2025 | 0.26 |
| Jun 30, 2025 | 0.25 |
| Mar 31, 2025 | 0.24 |
| Dec 31, 2024 | 0.23 |
| Sep 30, 2024 | 0.23 |
| Jun 30, 2024 | 0.24 |
| Mar 31, 2024 | 0.23 |
| Dec 31, 2023 | 0.22 |
| Sep 30, 2023 | 0.22 |
| Jun 30, 2023 | 0.24 |
| Mar 31, 2023 | 0.28 |
| Dec 31, 2022 | 0.45 |
| Sep 30, 2022 | 0.56 |
| Jun 30, 2022 | 0.63 |
| Mar 31, 2022 | 0.69 |
| Dec 31, 2021 | 0.80 |
| Sep 30, 2021 | 0.92 |